Alvotech Shares Start Trading on Nasdaq Iceland Main Market
December 08, 2022 03:30 ET | Alvotech
Listing on the Main Market can increase visibility, which may allow the company to appear in both domestic and global indexesAlvotech became first dual-listed Icelandic company in the U.S. and Iceland...
Hlutabréf Alvotech tekin til viðskipta á Aðalmarkaði Nasdaq á Íslandi
December 08, 2022 03:30 ET | Alvotech
Viðskipti með hlutabréf Alvotech á Aðalmarkaðnum auka sýnileika og breikka hóp mögulegra fjárfesta, auk þess opnar það leið til þátttöku í innlendum og alþjóðlegum hlutabréfavísitölumAlvotech varð í...
Alvotech_logo.jpg
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
December 08, 2022 03:30 ET | Alvotech
Robert Wessman Founder and Executive Chairman will ring the Nasdaq Iceland closing bell at 15:30 GMT on December 8, 2022Listing on the Main Market can increase visibility, which may allow the company...
betterlife pharma.png
BetterLife Announces Closing of Private Placement
December 07, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has...
Alvotech_logo.jpg
Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
December 07, 2022 04:00 ET | Alvotech
Hukyndra® (adalimumab) launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe Follows...
Alvotech_logo.jpg
Alvotech og STADA auka aðgengi sjúklinga að Hukyndra® (adalimumab) í Evrópu
December 07, 2022 04:00 ET | Alvotech
Hukyndra® (adalimumab) kemur nú á markað í Belgíu, Búlgaríu, Lettlandi, Króatíu, Rúmeníu, Slóveníu og Tékklandi en við það eykst aðgengi sjúklinga að adalimumab í háum styrk í EvrópuÁður var...
Alvotech_logo.jpg
Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
December 07, 2022 04:00 ET | Alvotech
Hukyndra® (adalimumab) launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe Follows...
Nasdaq Iceland Approves the Request for Trading of Alvotech’s Shares on the Main Market
December 02, 2022 10:41 ET | Alvotech
Nasdaq Iceland has approved Alvotech S.A’s (“Alvotech”) request for admission to trading of its shares on the Nasdaq Iceland Main Market (“Main Market”). Alvotech’s shares will be admitted to trading...
Nasdaq Iceland samþykkir beiðni um að taka hlutabréf Alvotech til viðskipta á Aðalmarkaðnum
December 02, 2022 10:41 ET | Alvotech
Nasdaq Iceland hefur samþykkt beiðni Alvotech S.A. (“Alvotech”, “félagið”) um að taka bréf félagsins til viðskipta á Aðalmarkaði Nasdaq Iceland. Bréf Alvotech verða tekin til viðskipta á Aðalmarkaðnum...
betterlife pharma.png
BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona
December 02, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...